Clinical trial
Effects of Chromium Supplementation on Parameters of the Metabolic Syndrome in…
NCT00145093 · Medical Research Foundation, The Netherlands, Other · Completed
Key facts
| NCT number | NCT00145093 |
|---|---|
| Title | Effects of Chromium Supplementation on Parameters of the Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus |
| Official title | The Effects of Organic Chromium Supplementation on Clinical Parameters of the Metabolic Syndrome, in Patients With Type 2 Diabetes Mellitus. A Randomised, Double-Blind, Placebo-Controlled Trial |
| Lead sponsor | Medical Research Foundation, The Netherlands, Other |
| Collaborators | Pharma Nord Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | Baker's yeast (Bio Chromium) |
| Enrollment | 60 |
| Start date | Aug 1, 2004 |
| Completion | Feb 1, 2005 |
| First posted | Sep 5, 2005 |
| Last update posted | Nov 22, 2005 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: